Medical Condition News

RSS

Yale researchers identify factors linked to disparities in cancer deaths

Yale researchers have identified factors that may contribute to widening cancer death disparities among counties across the United States.

5 Oct 2018

AI could be used to diagnose Alzheimer's years before symptoms appear

An Artificial Intelligence (AI) algorithm has been trained to pick up early signs of cognitive decline, which could result in Alzheimer’s disease (AD).

5 Oct 2018

A glass of wine a day may raise the risk of an early death

Even moderate drinking (four drinks or more per week) can increase the risk of cancer and an early death, according to a new study.

5 Oct 2018

Vitamin D supplements do not improve bone health, concludes study

Despite recommendations from governmental bodies around the world, vitamin D supplements do not benefit bone health. The conclusion follows one of the largest reviews ever of vitamin D.

5 Oct 2018

Predicting blood pressure with wearable off-the-shelf technology

Engineers at UC San Diego used wearable off-the-shelf technology and machine learning to predict, for the first time, an individual's blood pressure and provide personalized recommendations to lower it based on this data.

5 Oct 2018

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

5 Oct 2018

Study: Synthetic models can produce stress response similar to that of live tissue during simulation training

A study from the University of Minnesota Combat Casualty Training Consortium shows no significant differences between the use of live tissue models and synthetic training models in the learners' stress level.

5 Oct 2018

Study shows possibility of using PET imaging to manage chronic liver diseases

While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications. These effects may soon be a thing of the past for some patients thanks to new research showing PET imaging with the 18F-FAC radiotracer can be used as a non-invasive substitute. The study is featured in the October issue of The Journal of Nuclear Medicine.

5 Oct 2018

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers at the University of Illinois at Chicago have received a four-year, $5.25 million grant from the U.S. Department of Defense to lead a multi-site clinical trial to test the efficacy of a stem cell-based treatment for eye injuries.

5 Oct 2018

A new initiative to detect and prevent cancer in Southwest Virginia

A new University of Virginia Cancer Center initiative will empower Southwest Virginia residents to lead projects to better detect and prevent cancer in the region.

5 Oct 2018

Study analyzes role of environmental exposures in pediatric asthma control

A study from the Nationwide Children's Hospital analyzed environmental exposures, like pet and secondhand smoke, to determine if they have a role in asthma control among children whose asthma is managed per NAEPP (EPR-3) guidelines.

5 Oct 2018

Study shows adherence to annual lung cancer screening is not optimal

A study from the Thoracic Oncology Research Group (TORG), Division of Pulmonary and Critical Care, Medical University of South Carolina, aimed to examine the adherence to annual low-dose computed tomography (LDCT) screening after baseline LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project (LCDSDP).

5 Oct 2018

Study demonstrates benefits of using triple dual therapies in patients with COPD

The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.

5 Oct 2018

Review: Terminally-ill homeless adults face significant barriers in accessing palliative care

Terminally-ill homeless adults and their care providers must surmount many obstacles in the receipt and provision of palliative care, according to a University of Toronto scoping review of the available grey and peer-reviewed literature on this topic, published online this week in OMEGA - Journal of Death and Dying.

5 Oct 2018

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

5 Oct 2018

Study reveals factors linked to the development of Crohn's disease

How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry.

5 Oct 2018

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.

5 Oct 2018

Scientists receive Young Investigator Grants from Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation today announced the awarding of its Young Investigator Grants valued at more than $13.8 million to 200 of the world's most promising young scientists.

5 Oct 2018

New findings can promote healthy behavior among hypertensive women in Ghana

In the current issue of Family Medicine and Community Health (Volume 6,Number 3, 2018, pp.115-123, researchers Bishwajit Ghose and Sanni Yaya of the Faculty of Social Sciences, School of International Development and Global Studies University of Ottawa, Ottawa, ON, Canada, describe how this study is the first to assess the effect of socioeconomic status on blood pressure-controlling behavior among adult women with hypertension in Ghana.

5 Oct 2018

FDA approves HEMLIBRA for treatment of hemophilia A

Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.

5 Oct 2018